Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer

ClinicalTrials.gov ID: NCT00098787

Public ClinicalTrials.gov record NCT00098787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 4:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, irinotecan, leucovorin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of colorectal cancer by blocking blood flow to the tumor. Giving bevacizumab together with combination chemotherapy may be a better way to block tumor growth. Studying the amount of an enzyme found in the tumor may help doctors plan the best treatment. PURPOSE: This randomized phase II trial is studying giving bevacizumab, oxaliplatin, and irinotecan or giving bevacizumab, oxaliplatin, leucovorin, and fluorouracil in treating patients with metastatic or recurrent colorectal cancer.

Study identification

NCT ID
NCT00098787
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
247 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 8, 2005 (Actual)
Primary completion
Nov 2013 (Actual)
Completion
Apr 2015 (Actual)
Last update posted
Jul 5, 2023

2005 – 2015

United States locations

U.S. sites
110
U.S. states
18
U.S. cities
79
Facility City State ZIP Site status
California Cancer Care, Incorporated - Greenbrae Greenbrae California 94904 —
Aurora Presbyterian Hospital Aurora Colorado 80012 —
Boulder Community Hospital Boulder Colorado 80301-9019 —
Penrose Cancer Center at Penrose Hospital Colorado Springs Colorado 80933 —
St. Anthony Central Hospital Denver Colorado 80204 —
Porter Adventist Hospital Denver Colorado 80210 —
Presbyterian - St. Luke's Medical Center Denver Colorado 80218 —
St. Joseph Hospital Denver Colorado 80218 —
Rose Medical Center Denver Colorado 80220 —
CCOP - Colorado Cancer Research Program Denver Colorado 80224-2522 —
Swedish Medical Center Englewood Colorado 80110 —
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center Grand Junction Colorado 81502 —
North Colorado Medical Center Greeley Colorado 80631 —
Littleton Adventist Hospital Littleton Colorado 80122 —
Sky Ridge Medical Center Lone Tree Colorado 80124 —
Hope Cancer Care Center at Longmont United Hospital Longmont Colorado 80501 —
McKee Medical Center Loveland Colorado 80539 —
Parker Adventist Hospital Parker Colorado 80138 —
St. Mary - Corwin Regional Medical Center Pueblo Colorado 81004 —
North Suburban Medical Center Thornton Colorado 80229 —
Exempla Lutheran Medical Center Wheat Ridge Colorado 80033 —
University of Florida Shands Cancer Center Gainesville Florida 32610-0232 —
Winship Cancer Institute of Emory University Atlanta Georgia 30322 —
Veterans Affairs Medical Center - Atlanta (Decatur) Decatur Georgia 30033 —
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611-3013 —
Hematology and Oncology Associates Chicago Illinois 60611 —
Saint Joseph Hospital Chicago Illinois 60657 —
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526 —
Provena St. Mary's Regional Cancer Center - Kankakee Kankakee Illinois 60901 —
North Shore Oncology and Hematology Associates, Limited - Libertyville Libertyville Illinois 60048 —
Cancer Care and Hematology Specialists of Chicagoland - Niles Niles Illinois 60714 —
Swedish-American Regional Cancer Center Rockford Illinois 61104-2315 —
Hematology Oncology Associates - Skokie Skokie Illinois 60076 —
Elkhart General Hospital Elkhart Indiana 46515 —
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202-5289 —
Veterans Affairs Medical Center - Indianapolis Indianapolis Indiana 46202 —
William N. Wishard Memorial Hospital Indianapolis Indiana 46202 —
Howard Community Hospital Kokomo Indiana 46904 —
Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana 46350 —
Saint Joseph Regional Medical Center Mishawaka Indiana 46545-1470 —
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601 —
Memorial Hospital of South Bend South Bend Indiana 46601 —
McCreery Cancer Center at Ottumwa Regional Ottumwa Iowa 52501 —
Siouxland Hematology-Oncology Associates, LLP Sioux City Iowa 51101 —
Mercy Medical Center - Sioux City Sioux City Iowa 51102 —
St. Luke's Regional Medical Center Sioux City Iowa 51104 —
Borgess Medical Center Kalamazoo Michigan 49001 —
West Michigan Cancer Center Kalamazoo Michigan 49007-3731 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph Michigan 49085 —
Lakeside Cancer Specialists, PLLC Saint Joseph Michigan 49085 —
MeritCare Bemidji Bemidji Minnesota 56601 —
Fairview Ridges Hospital Burnsville Minnesota 55337 —
Mercy and Unity Cancer Center at Mercy Hospital Coon Rapids Minnesota 55433 —
Fairview Southdale Hospital Edina Minnesota 55435 —
Mercy and Unity Cancer Center at Unity Hospital Fridley Minnesota 55432 —
Hutchinson Area Health Care Hutchinson Minnesota 55350 —
HealthEast Cancer Care at St. John's Hospital Maplewood Minnesota 55109 —
Minnesota Oncology - Maplewood Maplewood Minnesota 55109 —
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital Minneapolis Minnesota 55407 —
Hennepin County Medical Center - Minneapolis Minneapolis Minnesota 55415 —
New Ulm Medical Center New Ulm Minnesota 56073 —
Humphrey Cancer Center at North Memorial Outpatient Center Robbinsdale Minnesota 55422-2900 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
Park Nicollet Cancer Center Saint Louis Park Minnesota 55416 —
Regions Hospital Cancer Care Center Saint Paul Minnesota 55101 —
United Hospital Saint Paul Minnesota 55102 —
St. Francis Cancer Center at St. Francis Medical Center Shakopee Minnesota 55379 —
Lakeview Hospital Stillwater Minnesota 55082 —
Ridgeview Medical Center Waconia Minnesota 55387 —
Willmar Cancer Center at Rice Memorial Hospital Willmar Minnesota 56201 —
Minnesota Oncology - Woodbury Woodbury Minnesota 55125 —
Cancer Resource Center - Lincoln Lincoln Nebraska 68510 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Immanuel Medical Center Omaha Nebraska 68122 —
Alegant Health Cancer Center at Bergan Mercy Medical Center Omaha Nebraska 68124 —
Lakeside Hospital Omaha Nebraska 68130 —
Creighton University Medical Center Omaha Nebraska 68131-2197 —
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton Marlton New Jersey 08053 —
CCOP - MeritCare Hospital Fargo North Dakota 58122 —
Roger Maris Cancer Center at MeritCare Hospital Fargo North Dakota 58122 —
Adena Regional Medical Center Chillicothe Ohio 45601 —
Case Comprehensive Cancer Center Cleveland Ohio 44106-5065 —
MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland Ohio 44109 —
Riverside Methodist Hospital Cancer Care Columbus Ohio 43214-3998 —
CCOP - Columbus Columbus Ohio 43215 —
Grant Medical Center Cancer Care Columbus Ohio 43215 —
Mount Carmel Health - West Hospital Columbus Ohio 43222 —
Doctors Hospital at Ohio Health Columbus Ohio 43228 —
Grady Memorial Hospital Delaware Ohio 43015 —
Fairfield Medical Center Lancaster Ohio 43130 —
St. Rita's Medical Center Lima Ohio 45801 —
Strecker Cancer Center at Marietta Memorial Hospital Marietta Ohio 45750 —
Knox Community Hospital Mount Vernon Ohio 43050 —
Licking Memorial Cancer Care Program at Licking Memorial Hospital Newark Ohio 43055 —
Southern Ohio Medical Center Cancer Center Portsmouth Ohio 45662 —
Community Hospital of Springfield and Clark County Springfield Ohio 45505 —
Genesis - Good Samaritan Hospital Zanesville Ohio 43701 —
Natalie Warren Bryant Cancer Center at St. Francis Hospital Tulsa Oklahoma 74136 —
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest Allentown Pennsylvania 18105 —
Bryn Mawr Hospital Bryn Mawr Pennsylvania 19010 —
Cancer Center of Paoli Memorial Hospital Paoli Pennsylvania 19301-1792 —
Fox Chase Cancer Center - Philadelphia Philadelphia Pennsylvania 19111-2497 —
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center Reading Pennsylvania 19612-6052 —
CCOP - Main Line Health Wynnewood Pennsylvania 19096 —
Lankenau Cancer Center at Lankenau Hospital Wynnewood Pennsylvania 19096 —
Avera Cancer Institute Sioux Falls South Dakota 57105 —
Sanford Cancer Center at Sanford USD Medical Center Sioux Falls South Dakota 57117-5039 —
Erlanger Cancer Center at Erlanger Hospital - Baroness Chattanooga Tennessee 37403 —
CCOP - Scott and White Hospital Temple Texas 76508 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00098787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2023 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00098787 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →